NASDAQ: SIBN

Si Bone Inc Stock Forecast, Predictions & Price Target

The consensus among 5 Wall Street analysts covering (NASDAQ: SIBN) stock is to Strong Buy SIBN stock.

Out of 5 analysts, 4 (80%) are recommending SIBN as a Strong Buy, 1 (20%) are recommending SIBN as a Buy, 0 (0%) are recommending SIBN as a Hold, 0 (0%) are recommending SIBN as a Sell, and 0 (0%) are recommending SIBN as a Strong Sell.

If you're new to stock investing, here's how to buy Si Bone stock.

(NASDAQ: SIBN) Si Bone's forecast annual revenue growth rate of 13.36% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 6.16%, and it is also forecast to beat the US market's average forecast revenue growth rate of 7.54%.

Si Bone's revenue in 2023 is $131,980,000.On average, 3 Wall Street analysts forecast SIBN's revenue for 2023 to be $5,531,832,226, with the lowest SIBN revenue forecast at $5,528,632,646, and the highest SIBN revenue forecast at $5,534,464,793. On average, 3 Wall Street analysts forecast SIBN's revenue for 2024 to be $6,566,835,869, with the lowest SIBN revenue forecast at $6,562,056,749, and the highest SIBN revenue forecast at $6,573,316,033.

In 2025, SIBN is forecast to generate $7,823,582,613 in revenue, with the lowest revenue forecast at $7,702,079,544 and the highest revenue forecast at $7,934,150,406.

According to 5 Wall Street analysts that have issued a 1 year SIBN price target, the average SIBN price target is $27.80, with the highest SIBN stock price forecast at $33.00 and the lowest SIBN stock price forecast at $25.00.

On average, Wall Street analysts predict that Si Bone's share price could reach $27.80 by Dec 4, 2024. The average Si Bone stock price prediction forecasts a potential upside of 51.91% from the current SIBN share price of $18.30.

(NASDAQ: SIBN) forecast ROE is N/A, which is considered weak.